Researchers studied 683 breast cancer patients’ preferences for involvement in treatment decision-making. They found that before consultation, most patients preferred shared or patient-directed treatment decision-making. Post-consultation, however, 43 percent of patients’ preferences changed — most changes indicated a preference for patient-directed decisions. Patients who were as involved as they wanted to be or were more involved than they wanted had significantly better decision-related outcomes than patients who were not as involved.
The authors said oncologists should encourage cancer patients to participate in treatment decision-making.
Related Articles on Hospital Oncology:
Ben Venue Laboratories Releases Limited Supply of Cancer Drug to Ease Shortage
CentraState Healthcare in New Jersey Opens $10M Radiation Oncology Suite
Kimmel Cancer Center at Jefferson in Philadelphia Creates Center to Eliminate Cancer Disparities
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
